Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
1994-10-3
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
May
|
| pubmed:issn |
0923-7534
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
5
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
473-4
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:7915538-Antineoplastic Agents,
pubmed-meshheading:7915538-Breast Neoplasms,
pubmed-meshheading:7915538-Drug Resistance,
pubmed-meshheading:7915538-Female,
pubmed-meshheading:7915538-Humans,
pubmed-meshheading:7915538-Paclitaxel,
pubmed-meshheading:7915538-Peripheral Nervous System Diseases,
pubmed-meshheading:7915538-Vinblastine
|
| pubmed:year |
1994
|
| pubmed:articleTitle |
Vinorelbine after paclitaxel in breast cancer: cross resistance and cumulative neurotoxicity?
|
| pubmed:publicationType |
Letter
|